Partner with the market leader in liquid biopsy, backed by the strongest legacy in blood-based NGS.1,2

Delivering comprehensive results in just 7 days.2*

References

Reduce barriers with an experienced partner to accelerate treatments
to market.

Accelerate patient reach with the market-leading liquid biopsy.³

Enhance patient outcomes with an FDA-approved CDx.2,4-6

CDx, companion diagnostic; NGS, next-generation sequencing.

*Turnaround time of 7 days is upon sample receipt.²

Next >

Home GuardantINFINITY™ FDA Approved Guardant360® CDx Guardant Reveal™ Guardant Infinity Platform™